231 related articles for article (PubMed ID: 30736442)
1. The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism.
Shin YS; Park JK
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30736442
[No Abstract] [Full Text] [Related]
2. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.
Corona G; Goulis DG; Huhtaniemi I; Zitzmann M; Toppari J; Forti G; Vanderschueren D; Wu FC
Andrology; 2020 Sep; 8(5):970-987. PubMed ID: 32026626
[TBL] [Abstract][Full Text] [Related]
3. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
4. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M
J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454
[TBL] [Abstract][Full Text] [Related]
5. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
Ko YH; Kim JJ
Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
[TBL] [Abstract][Full Text] [Related]
7. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
8. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
9. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
10. Late-onset hypogonadism: a concept comes of age.
Nieschlag E
Andrology; 2020 Nov; 8(6):1506-1511. PubMed ID: 31639279
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
[TBL] [Abstract][Full Text] [Related]
13. Critical evaluation of different available guidelines for late-onset hypogonadism.
Giagulli VA; Castellana M; Lisco G; Triggiani V
Andrology; 2020 Nov; 8(6):1628-1641. PubMed ID: 32593233
[TBL] [Abstract][Full Text] [Related]
14. EMAS position statement: Testosterone replacement therapy in the aging male.
Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
[TBL] [Abstract][Full Text] [Related]
15. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
Reyes-Vallejo L; Lazarou S; Morgentaler A
J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
[TBL] [Abstract][Full Text] [Related]
16. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
[TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement therapy.
Barbonetti A; D'Andrea S; Francavilla S
Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
[TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism.
Almehmadi Y; Yassin AA; Nettleship JE; Saad F
Arab J Urol; 2016 Mar; 14(1):31-6. PubMed ID: 26966591
[TBL] [Abstract][Full Text] [Related]
19. Late-onset Hypogonadism: Bone health.
Rochira V
Andrology; 2020 Nov; 8(6):1539-1550. PubMed ID: 32469467
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
